Oscar Health (OSCR) Scheduled to Post Earnings on Tuesday

Oscar Health (NYSE:OSCR) is set to announce its earnings results before the market opens on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.28 per share for the quarter. Oscar Health has set its FY 2024 guidance at EPS.Parties that wish to register for the company’s conference call can do so using this link.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Wednesday, February 7th. The company reported ($0.66) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.74) by $0.08. The firm had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Oscar Health had a negative return on equity of 29.99% and a negative net margin of 4.62%. Oscar Health’s quarterly revenue was up 43.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($1.05) EPS. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Oscar Health Trading Down 0.4 %

OSCR opened at $18.02 on Friday. The firm has a market capitalization of $4.14 billion, a P/E ratio of -15.02 and a beta of 1.66. The firm’s 50 day moving average is $15.30 and its 200-day moving average is $11.67. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.37. Oscar Health has a 52-week low of $4.72 and a 52-week high of $18.69.

Analyst Ratings Changes

A number of brokerages have commented on OSCR. Raymond James started coverage on shares of Oscar Health in a report on Friday, March 22nd. They issued an “outperform” rating and a $20.00 price objective on the stock. The Goldman Sachs Group boosted their price target on Oscar Health from $8.00 to $16.00 and gave the stock a “neutral” rating in a research note on Friday, February 9th. Wells Fargo & Company raised their price objective on Oscar Health from $12.00 to $20.00 and gave the company an “overweight” rating in a research note on Thursday, February 15th. Finally, TheStreet raised Oscar Health from a “d” rating to a “c-” rating in a research report on Wednesday, February 21st. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $13.50.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.